Taro to Release Third Quarter Results on January 24, 2023

Rhea-AI Summary

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is set to release its financial results for the third quarter ending December 31, 2022, on January 24, 2023, after market close. The announcement indicates the company's ongoing commitment to transparency and investor communication. The financial results can be accessed via Taro's website, enhancing shareholder engagement. Taro is focused on developing and manufacturing high-quality healthcare products to meet customer needs, positioning itself as a competitive entity in the pharmaceutical industry.

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022, after the close of market on Tuesday, January 24, 2023.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230119005893/en/

William J. Coote

VP, Chief Financial Officer

(914) 345-9001

William.Coote@taro.com

Source: Taro Pharmaceutical Industries Ltd.

FAQ

When will Taro Pharmaceutical Industries release its Q3 financial results?

Taro Pharmaceutical Industries plans to release its Q3 financial results on January 24, 2023, after market close.

Where can I find Taro's Q3 financial results?

Taro's Q3 financial results will be accessible on their official website at www.taro.com.

What is the period covered by Taro's upcoming financial results?

Taro's upcoming financial results cover the third quarter ended December 31, 2022.